“How can Acomplia be the deciding
factor in reducing obesity?” one may ask. By itself it cannot reduce or burn
fats but it helps someone in reducing his or her food intake. It acts as an
appetite suppressant. And as the appetite gets suppressed the food intake too
lessens. But if it is taken in conjunction to physical exercises and a
controlled diet program it can show a magnificent result in obesity reduction.
Thus, infusion of Acomplia (Rimonabant) can be the deciding factor in reducing
your obesity.
It is marketed by Sanofi-Aventis
as Acomplia in UK and EU. And it is rumoured that if Acomplia (Rimonabant) gets
FDA approval for sale in the USA it would be marketed as Zimulti. It is a
weight loss drug discovered and developed by Sanofi-Aventis. It is a new class
of CB1 blockers. It should be prescribed for persons who are with BMI of
30kg/m2 or more or overweight persons with 27kg/m2 with risk factors like
dyslipidaemia or type 2 diabetes. As per their claim if Acomplia 20mg tablet is
taken weight, waistline and triglycerides gets reduced plus it increases HDL-
cholesterol levels.
It has mild and short term side
effects like mood alteration with depressive disorders, dizziness, anxiety,
nausea etc. Acomplia Diet Pills should not be initiated in obese individuals
with renal or hepatic impairment or patients with psychiatric illness. One
should consult a doctor before taking this drug as it is a prescription drug.
Also remember that the individual results may vary.
If all the claims made by
Sanofi-Aventis are true then it is a pill worth giving a look in your search
for the ultimate weight loss pill. But as with any other diet pill it too
requires controlled diet program and exercises. And when both of these act
simultaneously with Acomplia (Rimonabant) it can work wonders for individuals
with excess weight.
No comments:
Post a Comment